Browse by People

Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Duarte, Rui, Boland, Angela ORCID: 0000-0002-5435-8644, Kotas, Eleanor, Dundar, Yenal, McEntee, Joanne and Ahmad, Sajjad (2019) Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 3 (4). pp. 453-461.

Lambe, Tosin ORCID: 0000-0002-6229-2454, Duarte, Rui, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Kotas, Eleanor, McEntee, Joanne and Pomeroy, Ian (2019) Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 37 (3). pp. 345-357.

Duarte, Rui, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Kotas, Eleanor and Mcentee, Joanne (2017) Cladribine for the treatment of relapsing-remitting multiple sclerosis. [Report]

Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Bryning, Samuel, Chaplin, Martha, Beale, Sophie, Boland, Angela ORCID: 0000-0002-5435-8644, McEntee, Joanne and Basu, Bristi (2023) Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer [ID4031]. [Report]

Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454, Dundar, Yenal, Kotas, Eleanor and McEntee, Joanne (2021) Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 5 (1). pp. 13-22.

Collapse authors list.
Duarte, Rui, Stainthorpe, Angela, Mahon, James, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Kotas, Eleanor, Boland, Angela ORCID: 0000-0002-5435-8644, Thom, Howard, Marshall, Tom et al (show 2 more authors) , Hall, Mark and Takwoingi, Yemisi (2019) Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation. PLOS ONE, 14 (12). e0226671-.

Collapse authors list.
Duarte, Rui, Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Richardson, Marty ORCID: 0000-0002-7097-8704, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Kotas, Eleanor, Boland, Angela ORCID: 0000-0002-5435-8644, Thom, Howard, Marshall, Tom et al (show 2 more authors) , Hall, Mark and Takwoingi, Yemisi (2020) Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24 (3). 1-+.

Collapse authors list.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Lambe, Tosin, Nevitt, Sarah, Mahon, James, Boland, Angela, Beale, Sophie, Dundar, Yenal, Edwards, Katherine, Bresnahan, Rebecca, McEntee, Joanne et al (show 1 more authors) and Moonim, Mufaddal (2020) Midostaurin for treating advanced systemic mastocytosis [ID1573]. [Report]

Collapse authors list.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah, Bresnahan, Rebecca, Boland, Angela, Beale, Sophie, Lambe, Tosin, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 1 more authors) and Boon, Cheng (2021) Nivolumab in combination with chemotherapy for untreated advanced gastric, gastro-oesophageal junction, or oesophageal adenocarcinoma [ID1465]. [Report]

Chaplin, Marty ORCID: 0000-0002-7097-8704, Bresnahan, Rebecca, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Houten, Rachel ORCID: 0000-0002-4315-7732, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley and Munot, Pinki (2023) Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15. PharmacoEconomics - Open, 7 (6). pp. 863-875.

Collapse authors list.
Bresnahan, Rebecca, Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 3 more authors) , Gandhi, Shreyans, Fleeman, Nigel ORCID: 0000-0002-4637-9779 and Chaplin, Marty ORCID: 0000-0002-7097-8704 (2023) Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - open, 7 (4). pp. 525-536.

Bresnahan, Rebecca, Houten, Rachel, Mahon, James, Beale, Sophie, Nevitt, Sarah, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne and Gandhi, Shreyans (2021) Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria [ID3746]. [Report]

Hounsome, Juliet ORCID: 0000-0002-2026-3778, Pilkington, Gerlinde ORCID: 0000-0003-0028-0746, Mahon, James, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Kotas, Eleanor, Renton, Tara and Dickson, Rumona ORCID: 0000-0003-1416-0913 (2020) Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation. Health Technology Assessment, 24 (30). 1-+.

Collapse authors list.
Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Chaplin, Marty, Edwards, Katherine, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley, Malik, Zafar et al (show 1 more authors) and Palmieri, Carlo ORCID: 0000-0001-9496-2718 (2023) Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 7 (3). pp. 345-358.

Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Houten, Rachel, Edwards, Katherine, Donegan, Sarah, Boland, Angela, Beale, Sophie, Dundar, Yenal and Mcentee, Joanne (2023) Upadacitinib for treating moderately to severely active ulcerative colitis [ID3953]. [Report]

Nicholson, Amanda, Mahon, James, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dwan, Kerry, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Hockenhull, Juliet ORCID: 0000-0002-2026-3778 and Dundar, Yenal (2015) The clinical effectiveness and cost-effectiveness of the PROGENSA (R) prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation. Health Technology Assessment, 19 (87). 1-+.

Collapse authors list.
Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Holmes, Hayden ORCID: 0000-0003-2559-061X, Arber, Mick, Nikolayevskyy, Vladyslav, Alagna, Riccardo, Manissero, Davide ORCID: 0000-0002-8887-8795, Dowdy, David, Migliori, Giovanni Battista, Sotgiu, Giovanni et al (show 1 more authors) and Duarte, Raquel (2022) A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations. BMC pulmonary medicine, 22 (1). 375-.